• KPT330 Improves Cas9 Precision via mRNA Export

  2026-09-11

  The reference study identifies selective inhibitors of nuclear export, including KPT330, as indirect modulators that improve the specificity of Cas9-based genome and base editing. Its central innovation is to control Cas9 activity by altering Cas9 mRNA export rather than by directly blocking the nuclease, creating a mechanistically distinct route to temporal editing control.

• Cholesterol: From Membrane Variable to Assay Logic

  2026-09-11

  Cholesterol is the principal sterol in membrane biology, but its value in mRNA-LNP research depends on how carefully its effects are separated from formulation and delivery variables. This article develops an assay-centered framework using intravesical p21 mRNA-LNP research to improve interpretation, controls, and translational decision-making.

• Autophagy and Resveratrol Apoptosis in RCC

  2026-09-10

  Yao, Fan, and He showed that resveratrol induces ROS-associated mitochondrial damage and caspase-3-dependent apoptosis in renal cell carcinoma 786-O cells, while simultaneously activating JNK-linked autophagy. The study’s central implication is that autophagy functions as a cytoprotective response, providing a mechanistic rationale for evaluating resveratrol together with autophagy inhibition in preclinical RCC models.

• EZ Cap™ Cas9 mRNA (m1Ψ) for CRISPR Editing

  2026-09-10

  EZ Cap™ Cas9 mRNA (m1Ψ) is an in vitro transcribed mRNA with Cap1 structure, m1Ψ modification, and a poly(A) tail for Cas9 expression. Its design supports CRISPR-Cas9 genome editing research, but the product does not by itself establish editing efficiency, specificity, delivery performance, or therapeutic safety.

• Forskolin for cAMP-Driven Cell Assays

  2026-09-09

  Forskolin is a direct adenylate cyclase activator for testing cAMP-dependent responses in stem-cell, neuroendocrine, and inflammatory models. This guide connects practical dosing and solvent controls with reproducible iPSC workflows, mesenchymal stromal-cell assays, and troubleshooting strategies.

• Mavorixafor hydrochloride in Cell Assays

  2026-09-09

  A scenario-based guide to using Mavorixafor hydrochloride (SKU A3174) in CXCR4-focused viability, proliferation, and cytotoxicity workflows. It covers formulation, controls, protocol optimization, interpretation, and practical vendor-selection criteria for reproducible laboratory studies.

• N4-Acetylcytidine: From Chemistry to Translation

  2026-09-08

  N4-Acetylcytidine is more than a modified nucleoside standard: it is a mechanistic probe for separating free ac4C metabolism from RNA-bound modification biology. Recent structural work on ASCH-domain proteins shows why that distinction matters for assay design, interpretation, and translational RNA research.

• EZ Cap™ Cas9 mRNA (m1Ψ) for Precision Editing

  2026-09-07

  A practical guide to using Cap1-capped, m1Ψ-modified Cas9 mRNA for transient CRISPR-Cas9 genome editing in mammalian cells. It connects reagent handling and dose-finding with nuclear-export biology, helping researchers improve reproducibility while separating product features from study-derived evidence.

• 3-Aminobenzamide (PARP-IN-1) Evidence

  2026-09-07

  3-Aminobenzamide, also called PARP-IN-1, is a research PARP inhibitor with a reported IC50 of approximately 50 nM in CHO-cell assays. Product and peer-reviewed evidence support its use for studying oxidative stress, vascular dysfunction, diabetic nephropathy, and PARP-linked host responses, but antiviral conclusions require separate validation.

• Cholesterol in Spatially Controlled mRNA Delivery

  2026-09-05

  Explore how Cholesterol connects membrane biophysics with localized mRNA nanoparticle research. This article translates a bladder cancer LNP study into practical decisions for formulation characterization, membrane assays, and reproducible sterol handling.

• Cyclic di-GMP, HipH, and Biofilm Persistence

  2026-09-04

  Liao et al. identify cyclic di-GMP as a small-molecule antitoxin that restrains the genotoxic toxin HipH during early biofilm development. The study links adhesion-stage signaling with DNA double-strand breaks, genome instability, and antibiotic persistence, providing a mechanistic framework for understanding biofilm resilience beyond diffusion or nutrient-limitation models.

• Breast Cancer Dependence on MCL-1: Study Analysis

  2026-09-04

  Campbell et al. show that established breast tumors depend on MCL-1 primarily because of its canonical anti-apoptotic activity, rather than a separate non-apoptotic tumor-supporting function. Genetic deletion, pharmacological inhibition, and BAX/BAK dependency experiments provide a mechanistic framework for interpreting MCL-1-directed apoptosis studies in breast cancer.

• ABT-888 (Veliparib) Workflow Guide

  2026-09-04

  ABT-888 (Veliparib) supports controlled PARP1/2 inhibition workflows for DNA repair studies, combination cytotoxicity assays, and preclinical sensitization models. This guide emphasizes model selection, exposure design, MSI tumor applications, and the critical need to verify whether PARP inhibition is relevant in each damage-response context.

• Cx43/NF-κB in AngII-Induced Macrophage Polarization

  2026-09-03

  The reference study shows that angiotensin II drives RAW264.7 macrophages toward a pro-inflammatory M1-like state through coordinated activation of Cx43 and NF-κB p65 signaling. By combining pathway inhibition with phenotypic, transcriptional, and cytokine measurements, it identifies Cx43 as a pharmacologically tractable regulator of AngII-associated inflammation while also highlighting the limits of inference from an immortalized macrophage model.

• Influenza Hemagglutinin (HA) Peptide Workflow

  2026-09-02

  Use the Influenza Hemagglutinin (HA) Peptide as a gentle competitive elution reagent for HA-tagged proteins, from routine immunoprecipitation to mechanistic IDH1 mutant studies. This workflow emphasizes controlled release, interaction preservation, assay controls, and troubleshooting rather than treating the peptide as a universal purification solution.

7942 records 1/530 page Next 12345 下5页 Last page